Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3302 USD | -8.28% | +5.43% | -56.38% |
May. 13 | PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 06 | PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index | CI |
Valuation
Fiscal Period: December | 2023 | 2024 |
---|---|---|
Capitalization 1 | 3.429 | 2.569 |
Enterprise Value (EV) 1 | 3.429 | 2.569 |
P/E ratio | -0.07 x | -0.31 x |
Yield | - | - |
Capitalization / Revenue | - | - |
EV / Revenue | - | - |
EV / EBITDA | - | - |
EV / FCF | - | - |
FCF Yield | - | - |
Price to Book | - | - |
Nbr of stocks (in thousands) | 4,530 | 7,780 |
Reference price 2 | 0.7570 | 0.3302 |
Announcement Date | 3/11/24 | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2023 | 2024 |
---|---|---|
Net sales 1 | - | - |
EBITDA | - | - |
EBIT 1 | -16.15 | -12.2 |
Operating Margin | - | - |
Earnings before Tax (EBT) 1 | -18.29 | -12.2 |
Net income 1 | -18.29 | -12.2 |
Net margin | - | - |
EPS 2 | -11.00 | -1.080 |
Free Cash Flow | - | - |
FCF margin | - | - |
FCF Conversion (EBITDA) | - | - |
FCF Conversion (Net income) | - | - |
Dividend per Share | - | - |
Announcement Date | 3/11/24 | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|
Net sales | - | - | - | - | - |
EBITDA | - | - | - | - | - |
EBIT | -4.386 | - | - | - | - |
Operating Margin | - | - | - | - | - |
Earnings before Tax (EBT) | -5.92 | - | - | - | - |
Net income | -5.92 | - | - | - | - |
Net margin | - | - | - | - | - |
EPS 1 | - | -0.5000 | -0.3000 | -0.2200 | -0.2100 |
Dividend per Share | - | - | - | - | - |
Announcement Date | 3/11/24 | 5/13/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2023 | 2024 |
---|---|---|
Net Debt | - | - |
Net Cash position | - | - |
Leverage (Debt/EBITDA) | - | - |
Free Cash Flow | - | - |
ROE (net income / shareholders' equity) | - | - |
ROA (Net income/ Total Assets) | - | - |
Assets 1 | - | - |
Book Value Per Share | - | - |
Cash Flow per Share | - | - |
Capex | - | - |
Capex / Sales | - | - |
Announcement Date | 3/11/24 | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.38% | 2.57M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PXMD Stock
- Financials PaxMedica, Inc.